Ubs Group Ag Senseonics Holdings, Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 834,653 shares of SENS stock, worth $383,940. This represents 0.0% of its overall portfolio holdings.

Number of Shares

834,653

Previous 1,143,994 27.04%

Holding current value

$383,940

Previous $755,000 47.02%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.48 - $0.77 $148,483 - $238,192	-309,341 Reduced 27.04%	834,653 $400,000
Q1 2025 May 13, 2025	SELL	$0.43 - $1.31 $1.56 Million - $4.75 Million	-3,625,193 Reduced 76.01%	1,143,994 $755,000
Q4 2024 Feb 14, 2025	BUY	$0.25 - $0.59 $1.18 Million - $2.78 Million	4,713,885 Added 8523.9%	4,769,187 $2.48 Million
Q3 2024 Nov 14, 2024	BUY	$0.32 - $0.49 $16,658 - $25,508	52,058 Added 1604.75%	55,302 $19,000
Q2 2024 Aug 13, 2024	SELL	$0.37 - $0.52 $23,245 - $32,669	-62,826 Reduced 95.09%	3,244 $1,000
Q1 2024 May 13, 2024	BUY	$0.5 - $0.73 $26,035 - $38,011	52,071 Added 371.96%	66,070 $35,000
Q4 2023 Feb 09, 2024	BUY	$0.48 - $0.7 $5,039 - $7,349	10,499 Added 299.97%	13,999 $7,000
Q3 2023 Nov 09, 2023	SELL	$0.5 - $1.05 $28,994 - $60,888	-57,989 Reduced 94.31%	3,500 $2,000
Q2 2023 Aug 11, 2023	SELL	$0.55 - $0.89 $90,196 - $145,954	-163,994 Reduced 72.73%	61,489 $46,000
Q1 2023 May 12, 2023	BUY	$0.68 - $1.25 $52,895 - $97,235	77,788 Added 52.67%	225,483 $160,000
Q4 2022 Feb 08, 2023	BUY	$0.96 - $1.34 $101,516 - $141,699	105,746 Added 252.08%	147,695 $152,000
Q3 2022 Nov 10, 2022	BUY	$1.02 - $2.23 $24,937 - $54,521	24,449 Added 139.71%	41,949 $55,000
Q2 2022 Aug 10, 2022	SELL	$0.94 - $1.94 $7,694 - $15,880	-8,186 Reduced 31.87%	17,500 $18,000
Q1 2022 May 16, 2022	SELL	$1.54 - $3.71 $134,652 - $324,391	-87,437 Reduced 77.29%	25,686 $51,000
Q4 2021 Feb 14, 2022	BUY	$2.58 - $3.91 $271,416 - $411,332	105,200 Added 1327.78%	113,123 $302,000
Q3 2021 Nov 15, 2021	SELL	$2.77 - $4.05 $54,452 - $79,614	-19,658 Reduced 71.27%	7,923 $27,000
Q2 2021 Aug 13, 2021	BUY	$1.71 - $4.14 $728 - $1,763	426 Added 1.57%	27,581 $105,000
Q1 2021 May 12, 2021	BUY	$0.85 - $5.27 $17,981 - $111,486	21,155 Added 352.58%	27,155 $72,000
Q3 2020 Nov 12, 2020	SELL	$0.36 - $0.53 $5,632 - $8,292	-15,646 Reduced 72.28%	6,000 $2,000
Q2 2020 Jul 31, 2020	SELL	$0.39 - $0.69 $20,694 - $36,613	-53,063 Reduced 71.03%	21,646 $8,000
Q1 2020 May 01, 2020	SELL	$0.56 - $1.62 $52,945 - $153,162	-94,545 Reduced 55.86%	74,709 $47,000
Q4 2019 Feb 14, 2020	SELL	$0.83 - $1.3 $62,976 - $98,637	-75,875 Reduced 30.95%	169,254 $155,000
Q3 2019 Nov 14, 2019	BUY	$0.97 - $1.94 $232,455 - $464,911	239,645 Added 4369.89%	245,129 $243,000
Q2 2019 Aug 14, 2019	SELL	$1.81 - $2.45 $6,649 - $9,001	-3,674 Reduced 40.12%	5,484 $11,000
Q1 2019 May 14, 2019	BUY	$2.3 - $3.27 $1,616 - $2,298	703 Added 8.31%	9,158 $23,000
Q4 2018 Feb 14, 2019	SELL	$2.49 - $4.54 $35,181 - $64,145	-14,129 Reduced 62.56%	8,455 $22,000
Q3 2018 Nov 14, 2018	BUY	$3.4 - $4.84 $42,935 - $61,119	12,628 Added 126.84%	22,584 $107,000
Q2 2018 Aug 14, 2018	BUY	$3.03 - $4.98 $25,924 - $42,608	8,556 Added 611.14%	9,956 $41,000
Q1 2018 May 15, 2018	BUY	$2.48 - $3.21 $992 - $1,284	400 Added 40.0%	1,400 $4,000
Q3 2017 Nov 14, 2017	SELL	$2.22 - $3.2 $668 - $963	-301 Reduced 23.14%	1,000 $3,000
Q2 2017 Aug 14, 2017	SELL	N/A	-589 Reduced 31.16%	1,301 $3,000
Q1 2017 Nov 14, 2017	BUY	N/A	1,890	1,890 $4,000

Others Institutions Holding SENS

# of Institutions

156

Shares Held

145M

Call Options Held

588K

Put Options Held

299K

View Full List

About Senseonics Holdings, Inc.

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $214M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

More about SENS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account